AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 11/15/2024
Closing price: 164.99
Support price level: | N/A |
Resistance price level: | $189.02 |
Relative strength index (14-day RSI) | 27.9 |
Beta | 0.27 |
- ABBV is one of this month's worst performers with a return of -12.6%, underperforming 90 percent of stocks in the S&P-100.
- Down 17.3 percent, ABBV is one of this week's biggest decliners.
- ABBV is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 54.4%.
- Volatility is forecast to fall over the next month.
- ABBV is below its 200-day moving average - additional caution warranted in long positions.
- With RSI < 30, ABBV is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
- Price crossed below 50-day moving average this week - a bearish signal.
Low | High | Price as % of Range |
$138.08 | $203.87 | 45.7% |
200 day | 50 day | 20 day | 10 day |
$178.93 | $192.04 | $189.13 | $185.38 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
24.9% | 22.3% | 54.4% | 36.4% |
- 14.8% in the next week.
- 20.6% in the next month.
- 46.0% in the next year.
Company news for AbbVie Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks